MX2012000539A - Regimen de rocio nasal de olopatadina para niños. - Google Patents
Regimen de rocio nasal de olopatadina para niños.Info
- Publication number
- MX2012000539A MX2012000539A MX2012000539A MX2012000539A MX2012000539A MX 2012000539 A MX2012000539 A MX 2012000539A MX 2012000539 A MX2012000539 A MX 2012000539A MX 2012000539 A MX2012000539 A MX 2012000539A MX 2012000539 A MX2012000539 A MX 2012000539A
- Authority
- MX
- Mexico
- Prior art keywords
- children
- nasal spray
- olopatadine nasal
- olopatadine
- regimen
- Prior art date
Links
- JBIMVDZLSHOPLA-LSCVHKIXSA-N olopatadine Chemical compound C1OC2=CC=C(CC(O)=O)C=C2C(=C/CCN(C)C)\C2=CC=CC=C21 JBIMVDZLSHOPLA-LSCVHKIXSA-N 0.000 title abstract 2
- 229960004114 olopatadine Drugs 0.000 title abstract 2
- 239000007922 nasal spray Substances 0.000 title 1
- 229940097496 nasal spray Drugs 0.000 title 1
- 238000000034 method Methods 0.000 abstract 2
- 230000000172 allergic effect Effects 0.000 abstract 1
- 208000010668 atopic eczema Diseases 0.000 abstract 1
- 208000027866 inflammatory disease Diseases 0.000 abstract 1
- 229940023490 ophthalmic product Drugs 0.000 abstract 1
- 239000012049 topical pharmaceutical composition Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M11/00—Sprayers or atomisers specially adapted for therapeutic purposes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0043—Nose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/12—Aerosols; Foams
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Otolaryngology (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Hematology (AREA)
- Heart & Thoracic Surgery (AREA)
- Biomedical Technology (AREA)
- Anesthesiology (AREA)
- Dispersion Chemistry (AREA)
- Pulmonology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Immunology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US22646909P | 2009-07-17 | 2009-07-17 | |
| PCT/US2010/042085 WO2011008923A2 (en) | 2009-07-17 | 2010-07-15 | Olopatadine nasal spray regimen for children |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2012000539A true MX2012000539A (es) | 2012-02-28 |
Family
ID=42664656
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2012000539A MX2012000539A (es) | 2009-07-17 | 2010-07-15 | Regimen de rocio nasal de olopatadina para niños. |
Country Status (17)
| Country | Link |
|---|---|
| US (2) | US20110011392A1 (OSRAM) |
| EP (1) | EP2453872B1 (OSRAM) |
| JP (1) | JP2012533554A (OSRAM) |
| KR (1) | KR20120046215A (OSRAM) |
| CN (2) | CN102470099A (OSRAM) |
| AU (1) | AU2010273347B2 (OSRAM) |
| BR (1) | BR112012001169A2 (OSRAM) |
| CA (1) | CA2768006A1 (OSRAM) |
| DK (1) | DK2453872T3 (OSRAM) |
| ES (1) | ES2432502T3 (OSRAM) |
| HR (1) | HRP20130946T1 (OSRAM) |
| MX (1) | MX2012000539A (OSRAM) |
| PL (1) | PL2453872T3 (OSRAM) |
| PT (1) | PT2453872E (OSRAM) |
| SI (1) | SI2453872T1 (OSRAM) |
| WO (1) | WO2011008923A2 (OSRAM) |
| ZA (1) | ZA201109320B (OSRAM) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9370483B2 (en) | 2013-09-13 | 2016-06-21 | Glenmark Specialty S.A. | Stable fixed dose pharmaceutical composition comprising mometasone and olopatadine |
| US9937189B2 (en) | 2013-09-13 | 2018-04-10 | Glenmark Specialty S.A. | Stable fixed dose pharmaceutical composition comprising mometasone and olopatadine |
| US10646500B2 (en) | 2013-10-04 | 2020-05-12 | Glenmark Specialty S.A. | Treatment of allergic rhinitis using a combination of mometasone and olopatadine |
| US10653661B2 (en) | 2013-10-04 | 2020-05-19 | Glenmark Specialty S.A. | Treatment of allergic rhinitis using a combination of mometasone and olopatadine |
| US10548907B2 (en) | 2013-10-04 | 2020-02-04 | Glenmark Specialty S.A. | Treatment of allergic rhinitis using a combination of mometasone and olopatadine |
| US10758550B2 (en) | 2013-10-04 | 2020-09-01 | Glenmark Specialty S.A. | Treatment of allergic rhinitis using a combination of mometasone and olopatadine |
| US10016443B2 (en) | 2013-10-04 | 2018-07-10 | Glenmark Specialty S.A. | Treatment of allergic rhinitis using a combination of mometasone and olopatadine |
| US11679210B2 (en) | 2014-10-03 | 2023-06-20 | Glenmark Specialty S.A. | Dispensing device and pharmaceutical composition for the treatment of rhinitis |
| CN107569454B (zh) * | 2017-09-29 | 2018-05-04 | 深圳大佛药业股份有限公司 | 一种盐酸奥洛他定鼻喷雾剂及其制备方法 |
| HRP20250411T1 (hr) | 2018-02-23 | 2025-07-18 | Glenmark Specialty S.A. | Liječenje alergijskog rinitisa kod pedijatrijskih subjekata kombinacijom mometazona i olopatadina |
| US12303635B2 (en) | 2018-04-16 | 2025-05-20 | Glenmark Specialty S.A. | Dispensing device and pharmaceutical composition for the treatment of rhinitis |
| CN109806224B (zh) * | 2019-03-15 | 2021-05-28 | 江苏长泰药业有限公司 | 一种奥洛他定组合物及其制备方法 |
| JP2023533628A (ja) * | 2020-02-06 | 2023-08-04 | ホライズン アイピー テック エルエルシー | 慢性及び長期の鼻づまりを治療する方法、装置、及びキット |
| WO2025137749A1 (pt) * | 2023-12-27 | 2025-07-03 | Eurofarma Laboratórios S.A. | Processo de solubilização de olopatadina e seu uso |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8520662D0 (en) | 1985-08-17 | 1985-09-25 | Wellcome Found | Tricyclic aromatic compounds |
| US4923892A (en) | 1985-08-17 | 1990-05-08 | Burroughs Wellcome Co. | Tricyclic aromatic compounds |
| JPS6310784A (ja) * | 1986-03-03 | 1988-01-18 | Kyowa Hakko Kogyo Co Ltd | 抗アレルギー剤 |
| SE8704767L (sv) * | 1987-11-30 | 1989-05-31 | Sigmund Johannes Loefstedt | Ny metod foer administrering av laekemedel |
| US5641805A (en) * | 1995-06-06 | 1997-06-24 | Alcon Laboratories, Inc. | Topical ophthalmic formulations for treating allergic eye diseases |
| JP2005281315A (ja) * | 1997-07-02 | 2005-10-13 | Aventis Pharmaceuticals Holdings Inc | 水性薬理組成物 |
| GB9918559D0 (en) * | 1999-08-07 | 1999-10-06 | Glaxo Wellcome Kk | Novel pharmaceutical formulation |
| GB0014947D0 (en) * | 2000-06-16 | 2000-08-09 | Glaxo Group Ltd | Novel pharmaceutical formulation |
| TWI231759B (en) * | 2001-06-27 | 2005-05-01 | Alcon Inc | Olopatadine formulations for topical administration |
| US7977376B2 (en) * | 2001-06-27 | 2011-07-12 | Novartis Ag | Olopatadine formulations for topical nasal administration |
| US20040214754A1 (en) * | 2001-10-03 | 2004-10-28 | Ellis Edward J. | Ophthalmic preparation containing glycomacropeptide |
| US20030004179A1 (en) * | 2002-05-21 | 2003-01-02 | Affrime Melton B | Treating allergic and inflammatory conditions |
| EP1596822A2 (en) * | 2003-02-17 | 2005-11-23 | Sun Pharmaceuticals Industries Ltd. | A low dose corticosteroid composition |
| DK1814538T3 (da) * | 2004-11-24 | 2009-11-02 | Alcon Inc | Fremgangsmåde til administration af næsespray |
| WO2008097220A1 (en) * | 2007-02-07 | 2008-08-14 | Alcon, Inc. | Olopatadine formulations for topical nasal administration |
-
2010
- 2010-07-15 AU AU2010273347A patent/AU2010273347B2/en not_active Ceased
- 2010-07-15 KR KR1020127002796A patent/KR20120046215A/ko not_active Ceased
- 2010-07-15 CN CN2010800323582A patent/CN102470099A/zh active Pending
- 2010-07-15 US US12/836,834 patent/US20110011392A1/en not_active Abandoned
- 2010-07-15 EP EP10735130.6A patent/EP2453872B1/en not_active Not-in-force
- 2010-07-15 WO PCT/US2010/042085 patent/WO2011008923A2/en not_active Ceased
- 2010-07-15 PL PL10735130T patent/PL2453872T3/pl unknown
- 2010-07-15 BR BR112012001169A patent/BR112012001169A2/pt not_active IP Right Cessation
- 2010-07-15 HR HRP20130946AT patent/HRP20130946T1/hr unknown
- 2010-07-15 DK DK10735130.6T patent/DK2453872T3/da active
- 2010-07-15 CN CN201410246743.7A patent/CN104173273A/zh active Pending
- 2010-07-15 SI SI201030341T patent/SI2453872T1/sl unknown
- 2010-07-15 JP JP2012520770A patent/JP2012533554A/ja active Pending
- 2010-07-15 ES ES10735130T patent/ES2432502T3/es active Active
- 2010-07-15 MX MX2012000539A patent/MX2012000539A/es active IP Right Grant
- 2010-07-15 PT PT107351306T patent/PT2453872E/pt unknown
- 2010-07-15 CA CA2768006A patent/CA2768006A1/en not_active Abandoned
-
2011
- 2011-12-19 ZA ZA2011/09320A patent/ZA201109320B/en unknown
-
2013
- 2013-09-10 US US14/022,528 patent/US20140007865A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| JP2012533554A (ja) | 2012-12-27 |
| BR112012001169A2 (pt) | 2016-03-01 |
| AU2010273347A1 (en) | 2012-03-08 |
| US20110011392A1 (en) | 2011-01-20 |
| ES2432502T3 (es) | 2013-12-03 |
| CN102470099A (zh) | 2012-05-23 |
| WO2011008923A3 (en) | 2011-12-08 |
| CN104173273A (zh) | 2014-12-03 |
| CA2768006A1 (en) | 2011-01-20 |
| PT2453872E (pt) | 2013-10-30 |
| DK2453872T3 (da) | 2013-10-07 |
| AU2010273347B2 (en) | 2015-04-30 |
| WO2011008923A2 (en) | 2011-01-20 |
| ZA201109320B (en) | 2013-03-27 |
| US20140007865A1 (en) | 2014-01-09 |
| HRP20130946T1 (hr) | 2013-11-08 |
| EP2453872A2 (en) | 2012-05-23 |
| SI2453872T1 (sl) | 2013-10-30 |
| EP2453872B1 (en) | 2013-08-21 |
| KR20120046215A (ko) | 2012-05-09 |
| PL2453872T3 (pl) | 2013-12-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PT2453872E (pt) | Regime de pulverização nasal de olopatadina para crianças | |
| NZ704247A (en) | Compositions and treatment for eye diseases and disorders | |
| ZA201208535B (en) | Formulations of quinones for the treatment of ophthalmic diseases | |
| WO2013016668A3 (en) | Methylphenidate-prodrugs, processes of making and using the same | |
| CY1122565T1 (el) | Συνθεσεις και μεθοδοι μη χειρουργικης θεραπειας βλεφαροπτωσης | |
| EP2424360A4 (en) | TOPICAL, PERIOCULAR OR INTRAOCULAR USE OF TOCOTRIENOLS FOR THE TREATMENT OF OPHTHALMIC DISEASES | |
| EP3113821A4 (fr) | Masque facial pour inhalation, adapte a l'administration d'un gaz ou d'une molécule thérapeutique dans le cadre d'un traitement par inhalation, en particulier chez les enfants | |
| MX2014002395A (es) | Inhibidores de rock suaves, novedosos. | |
| CY1119603T1 (el) | Οιστρογονικα παραγωγα για χρηση στην αγωγη νευρολογικων διαταραχων | |
| WO2012009171A3 (en) | Compositions and methods of treatment of corneal endothelium disorders | |
| ATE519756T1 (de) | Prophylaktikum bzw. therapeutikum für altersbedingte makuladegeneration | |
| WO2012135619A3 (en) | Intranasal benzodiazepine pharmaceutical compositions | |
| WO2012047525A3 (en) | Folate conjugates for treating inflammation of the eye | |
| WO2014160281A3 (en) | Method of enhancing delivery of therapeutic compounds to the eye | |
| TN2014000046A1 (en) | Substituted 3-(biphenyl-3-yl)-4-hydroxy-8-methoxy-1-azaspiro[4.5]dec-3-en-2-one | |
| IN2014CN03123A (OSRAM) | ||
| WO2014161004A3 (en) | Compositions and methods for the delivery of drugs to the ocular surface by contact lenses | |
| GB201213484D0 (en) | Pharmaceutical compositions comprising 15-OHEPA and methods of using the same | |
| TN2016000121A1 (en) | Cyclic thienouracil-carboxamides and use thereof | |
| MX356317B (es) | Tratamiento de síntomas asociados a gastroparesia femenina. | |
| MX2009008548A (es) | Formulaciones de olopatadina para administracion nasal topica. | |
| MX369774B (es) | Uso de pregn-4-en-20-in-3-ona para el tratamiento de trastornos depresivos. | |
| HK1219654A1 (zh) | 用於治疗眼科疾病和病症的方法 | |
| EA201492088A1 (ru) | Комбинированное терапевтическое средство для лечения ринита | |
| WO2012125663A3 (en) | Cyclohexane substituted amino cyclopentane derivatives as useful ccr2 antagonists |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant or registration |